title: Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy.
authors.forename: José-Tomás
authors.initials: JT
authors.lastname: Navarro
authors.forename: Josep-Maria
authors.initials: JM
authors.lastname: Ribera
authors.forename: Albert
authors.initials: A
authors.lastname: Oriol
authors.forename: Cristina
authors.initials: C
authors.lastname: Tural
authors.forename: Fuensanta
authors.initials: F
authors.lastname: Millá
authors.forename: Evarist
authors.initials: E
authors.lastname: Feliu
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D002051:Burkitt Lymphoma / Q000150:complications / Q000188:drug therapy; D003131:Combined Modality Therapy; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis